A detailed history of Royal Bank Of Canada transactions in Inogen Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 2,681 shares of INGN stock, worth $25,147. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,681
Previous 2,609 2.76%
Holding current value
$25,147
Previous $21,000 23.81%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.67 - $12.98 $552 - $934
72 Added 2.76%
2,681 $26,000
Q2 2024

Aug 14, 2024

SELL
$6.3 - $8.95 $257,890 - $366,368
-40,935 Reduced 94.01%
2,609 $21,000
Q1 2024

Nov 05, 2024

BUY
$5.26 - $10.15 $215,318 - $415,490
40,935 Added 1568.99%
43,544 $351,000
Q1 2024

May 15, 2024

BUY
$5.26 - $10.15 $185,031 - $357,046
35,177 Added 420.43%
43,544 $351,000
Q4 2023

Feb 14, 2024

BUY
$4.21 - $6.32 $16,389 - $24,603
3,893 Added 87.01%
8,367 $45,000
Q3 2023

Nov 14, 2023

BUY
$5.14 - $11.28 $7,093 - $15,566
1,380 Added 44.6%
4,474 $23,000
Q2 2023

Aug 14, 2023

BUY
$10.01 - $13.86 $10,450 - $14,469
1,044 Added 50.93%
3,094 $35,000
Q1 2023

May 15, 2023

SELL
$11.88 - $26.0 $27,692 - $60,606
-2,331 Reduced 53.21%
2,050 $25,000
Q4 2022

Feb 14, 2023

BUY
$19.14 - $24.55 $68,540 - $87,913
3,581 Added 447.63%
4,381 $86,000
Q3 2022

Nov 14, 2022

BUY
$22.74 - $31.8 $5,616 - $7,854
247 Added 44.67%
800 $20,000
Q2 2022

Aug 15, 2022

SELL
$22.88 - $35.28 $24,893 - $38,384
-1,088 Reduced 66.3%
553 $14,000
Q1 2022

May 16, 2022

SELL
$28.1 - $35.25 $53,727 - $67,398
-1,912 Reduced 53.81%
1,641 $53,000
Q4 2021

Feb 14, 2022

SELL
$29.66 - $44.0 $16,995 - $25,212
-573 Reduced 13.89%
3,553 $120,000
Q3 2021

Nov 15, 2021

BUY
$43.09 - $82.26 $26,801 - $51,165
622 Added 17.75%
4,126 $177,000
Q2 2021

Aug 16, 2021

BUY
$52.03 - $68.77 $182,313 - $240,970
3,504 New
3,504 $228,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $214M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.